Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.

Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.

Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...

Two Seas Capital has come out against Core Scientific's proposed all-stock acquisition by AI cloud provider CoreWeave.

Two Seas Capital claims to own 6.3% of Core Scientific’s outstanding stock. While Vanguard and Blackrock are the largest ...

Two Seas Capital is challenging Core Scientific’s $9 billion sale to CoreWeave, arguing the terms significantly undervalue ...

Two Seas Capital opposes CoreWeave’s acquisition of Core Scientific, citing shareholder risk and sparking debate on AI infrastructure deals.

Core Scientific's largest shareholder, Two Seas Capital LP, has announced its opposition to the $9bn acquisition proposed by ...

CoreWeave’s acquisition of Core Scientific is facing shareholder pushback, sparking a rally in AI tokens and centralization questions.

Two Seas Capital, the largest shareholder of Core Scientific , issued an open letter on Thursday saying it would vote against ...

One of Core Scientific’s biggest investors has threatened to launch a revolt against CoreWeave’s planned purchase of the group, arguing the deal’s structure is “deficient” and could undervalue it.

The crap is coming… from inside the house; Two Seas wants to sink CoreWeave deal; Jamie Dimon’s summer vacation; and more!